恶性胸腔积液引流留置胸腔导管置入中的针道种植:发生率及相关临床与影像因素
该回顾性研究纳入2011年1月至2021年12月间124例因恶性胸腔积液行留置胸腔导管置入的患者,评估针道种植的发生率及相关因素。针道种植发生率为21.7%(27/124),腺癌(19/27,70.3%)为最常见细胞类型,纵隔胸膜增厚与针道种植发生显著相关(OR 9.79,95%CI 2.67-35.84,p=0.001)。
要点
- 留置胸腔导管相关针道种植发生率为21.7%(27/124例恶性胸腔积液)。
- 纵隔胸膜增厚与针道种植发生显著相关(OR 9.79,95%CI 2.67-35.84,p=0.001)。
- 肿瘤体积、导管留置时间、生存天数及胸腔积液量均与针道种植无关。
核心结论
- 留置胸腔导管针道种植见于124例恶性胸腔积液患者中的27例(21.7%),尤其多见于腺癌细胞学患者;CT示纵隔胸膜增厚与针道种植发生相关。
研究设计与样本
- 回顾性研究,纳入2011年1月至2021年12月间连续124例因恶性胸腔积液引流行留置胸腔导管置入的患者,获取置管前胸部X线片及系列胸部CT,1例经病理诊断、其余经影像学诊断针道种植,通过复习病历和影像学评估发生率及相关因素。
关键影像表现/征象
- CT示纵隔胸膜增厚与针道种植发生显著相关(OR 9.79,95%CI 2.67-35.84,p=0.001)。
- 针道种植组中腺癌为最常见细胞类型(19/27,70.3%),其中肺来源12例、胸外恶性肿瘤来源7例。
- 27例针道种植患者中15例为原发性肺癌,其余12例为胸外恶性肿瘤。
诊断标准与关键数值
- 针道种植发生率为21.7%(27/124例恶性胸腔积液)。
- 自留置胸腔导管置入至针道种植发生的平均时间为96天(范围28-306天)。
- 针道种植组置管后生存期为185天(范围32-457天)。
临床应用与阅片要点
- 阅片时注意评估纵隔胸膜增厚,该征象与留置胸腔导管针道种植发生相关(OR 9.79,95%CI 2.67-35.84,p=0.001)。
- 肿瘤体积、导管留置时间、置管后生存天数及胸腔积液量均与针道种植无关(分别为p=0.168、p=0.142、p=0.26、p=0.481)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: The incidence of tract seeding after the placement of indwelling pleural catheter (IPC) for malignant pleural effusion drainage has been variable in the literature.
RESEARCH QUESTION: To evaluate the incidence of IPC-related cancer tract seeding and find out related demographic, clinical or imaging factors to the tract seeding.
STUDY DESIGN AND METHODS: This retrospective study included 124 consecutive patients seen between January 2011 and December 2021 who underwent IPC placement for malignant pleural effusion drainage. Chest radiographs before IPC placement and serial chest CT studies were obtained. One patient was diagnosed pathologically, and the other patients were diagnosed as tract seeding radiologically. The incidence of and related factors to tract seeding were assessed by reviewing medical records and imaging studies.
RESULTS: The incidence of IPC tract seeding was 21.7% (27 of 124 malignant effusions). Of 27 patients, 15 had primary lung cancer and remaining 12 had extra-thoracic malignancy. Adenocarcinoma (19 of 27, 70.3%) either from the lung (N = 12) or extra-thoracic malignancy (N = 7) was the most common cell type. Mean time elapsed until tract seeding occurrence after IPC placement was 96 days (ranges; 28-306 days). The survival in seeding group after IPC placement was 185 days (ranges, 32-457 days). On odd ratio analysis, the presence of mediastinal pleural thickening (OR [95% CI]; 9.79 (2.67-35.84), p = 0.001) was significantly related to the occurrence of tract seeding. Neither tumor volume within pleural space (p = 0.168), duration of IPC indwelling (p = 0.142), days of survival after IPC placement (p = 0.26), nor pleural effusion amount (p = 0.481) was related to the tract seeding.
INTERPRETATION: IPC tract seeding is seen in 27 (21.7%) of 124 malignant pleural effusion patients, particularly with adenocarcinoma cytology. CT features of mediastinal pleural thickening are related to the occurrence of tract seeding.
引用
- Song YG, Lee MO, Nam Y, et al. Tract seeding in indwelling pleural catheter placement for the drainage of malignant pleural effusions: Incidence and related clinical and imaging factors. Eur J Radiol. 2023. PMID: 37459688. doi:10.1016/j.ejrad.2023.110976
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。